Abstract
There is a wide divergence between the prevalence of rheumatic diseases seen in hospital practice and those for which antirheumatic medication is prescribed in the community (Fig. 10.1). In a rheumatism clinic inflammatory joint disease predominates. In general practice degenerative conditions are far commoner. In a recent analysis of side effects of indoprofen in general practice I surveyed the types of arthritis for which it was prescribed in Leeds. Of 427 patients only 10% had inflammatory arthritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennett, R. M., Lehr, J. R. and McCarty, D. J. (1976) Crystal shedding and acute pseudogout. Arthr. Rheum., 19, 93–7.
Bird, H. A., Dixon, J. S., Finney, B. L., Leatham, P. A., Lowe, J. R., Pickup, M. E., Rhind, V. M., Rushton, A., Sitton, N. G. and Wright, V. (1983) A clinical and biochemical evaluation of Clozic, a novel disease modifying drug in rheumatoid arthritis. Clin. Exp. Rheumatol., 1, 93–100.
Bird, H. A., Dixon, J. S., Pickup, M. E., Rhind, V. M., Lowe, J. R., Lee, M. R. and Wright, V. (1982a) A biochemical assessment of sulphasalazine in rheumatoid arthritis. J. Rheumatol., 9, 36–45.
Bird, H. A., Leatham, P. A., Dixon, J. S., Sitton, M. G. and Wright, V. (1982b) Failure of trien to improve rheumatoid arthritis. Ann. Rheum. Dis., 41, 314–15.
Bird, H. A., Rhind, V. M., Pickup, M. E. and Wright, V. (1980) A comparative study of benoxoprofen and indomethacin in ankylosing spondylitis. J. Rheumatol., 7 (Suppl. 6), 139–42.
Bird, H. A. and Wright, V. (1982) Applied Drug Therapy of Rheumatic Diseases, Wright, Bristol.
Bitter, T., Bahous, I. and Rosenthal, M. (1981) All-trans retinoic acid (R): a remission aim in the treatment of psoriatic arthritis. Ann. Rheum. Dis., 40, 209.
Boxer, L. A., Allen, J. M., Schmidt, M., Tocler, M. and Badiner, R. L. (1980) Inhibition of polymorphonuclear-leucocyte adherence by prostacyclin. J. Lab. Clin. Med., 95, 672–5.
Brühl, W., Swierczynska, Z. and Cygler, B. (1979) Clinical and immunological effects of pyrithioxine treatment in RA patients. 9th Eur. Congr. Rheumatol., Wiesbaden, West Germany, Abstract 243.
Calguneri, M., Swinburn, L., Cooke, E. M. and Wright, V. (1981) Secretory IgA immune defence pattern in ankylosing spondylitis and Klebsiella. Ann. Rheum. Dis., 40, 600–4.
Calin, P., Ebringer, R. and Ebringer, A. (1981) Association of inflammation with elevated serum IgA in ankylosing spondylitis. Ann. Rheum. Dis., 39, 545–9.
Campbell, P. M., and Leroy, E. C. (1975) Pathogenesis of systemic sclerosis: a vascular hypothesis. Seminars Arthr. Rheum., 4, 351–68.
Camus, A., Jaffe, I. A. and Grouzet, J. (1978) La pyrithioxine: nouveau traitement de fond de la polyarthrite rhumatoide. Rev. Rhum., 45, 95–100.
Chandler, G. N. and Wright, V. (1958) Deleterious effect of intra-articular hydrocortisone. Lancet, ii, 661–3.
Clifford, P. C., Martin, M. F. R., Sheddon, E. J., Kirby, J. D., Baird, R. N. and Dieppe, P. A. (1980) Treatment of vasospastic disease with prostaglandin E1. Br. Med. J., 281, 1031–4.
Cooke, A. F. and Gvozdanovic, D. D. (1981) Synthetic lubricants of synovial joints. In (eds D. Dowson and V. Wright), Introduction to the Biomechanics of Joints and Joint Replacements Mechanical Engineering Publications, London, pp. 139–43.
Cox, B. M., Goldstein, A. and Li, C. H. (1976) Opioid activity of a peptide, β lipotropin-(61–91), derived from β-lipotropin. Froc. Nat. Acad. Sci., USA, 73, 1821–3.
Dequeker, J., Naesens, M. and Martens, J. (1981) The effect of plasma exchange on synovitis in rheumatoid arthritis. Scand. J. Rheumatol., 10, 273–90.
Dieppe, P. A. (1977) Crystal-induced inflammation and osteoarthritis, in Perspectives in Inflammation: Future Trends and Developments (eds D. A. Willoughby, J. P. Giraud and G. P. Vely), MTP Press, Lancaster, pp. 225–37.
Dixon, J. S. and Bird, H. A. (1981) Reproducibility along a 10 cm vertical visual analogue scale. Ann. Rheum. Dis., 40, 87–9.
Dixon, J. S., Bird, H. A., Pickup, M. E. and Wright, V. (1982) A human model screening system for the detection of specific anti-rheumatic activity. Seminars Arthr. Rheum., 12, 185–90.
Dixon, J. S., Bird, H. A. and Wright, V. (1981) The pseudo-science of visual analogue scales. 15th Int. Congr. Rheumatol., Paris. Abstract 1388. Revue Rheumatologie. Special Issue.
Dowd, P. M., Martin, M. F. R., Cooke, E. D., Bowcock, S. A., Jones, R., Dieppe, P. A. and Kirby, J. D. T. (1982) Treatment of Raynaud’s phenomenon by intravenous infusion of prostacyclin (PGI2). Br. J. Dermatol, 106, 81–9.
Downie, W. W., Leatham, P. A., Rhind, V. M., Wright, V., Branter, J. A. and Anderson, J. A. (1978) Studies with pain rating scales. Ann. Rheum. Dis., 37, 378–81.
Dunn, C. J., Willoughby, D. A., Giroud, J. P. and Yamamoto, S. (1976) An appraisal of the interrelationships between prostaglandins and cyclic nucleotides in inflammation. Biomedicine, 24, 214–20.
Ellis, B. W., Johns, M. W., Lancaster, R., Raptopoulos, P., Angelopoulos, N. and Priest, R. G. (1981) The St. Mary’s Hospital sleep questionnaire: a study of reliability. Sleep, 41, 93–7.
Fagrell, B. (1977) The skin microcirculation and the pathogenesis of ischaemic necrosis and gangrene. Scand. J. Clin. Lab. Invest., 37, 473–6.
Fagrell, B., Fronek, A. and Intaglietta, M. (1977) A microscope-television system for studying flow velocity in human skin capillaries. Am. J. Physiol., 233, 318–21.
Fauci, A. S., Haynes, B. F. and Katz, P. (1978) The spectrum of vasculitis. Ann. Intern. Med., 89, 660–6.
Franks, A. G. (1982) Topical glyceryl trinitrate as adjunctive treatment in Raynaud’s disease. Lancet, i, 76–7.
Gilliam, J. N. and Smiley, J. D. (1976) Cutaneous necrotising vasculitis and related disorders. Ann. Allergy, 37, 328–39.
Greenfield, S. S. and Hawks, G. W. (1981) Visual analogue scale. Br. J. Clin. Pharmacol., 11, 98.
Gregoriadis, G. (1980) Tailoring liposome structure. Nature, 283, 814–15.
Grennan, D. M., Ferry, D. G. and Ashworth, M. E. (1979) The aspirin-ibuprofen interaction in rheumatoid arthritis. Br. J. Clin. Pharmacol., 8, 497–504.
Heilman, K. (1978) Therapeutic systems. Patterns Specific Drug Delivery: Concepts and Development, Georg Thieme, Stuttgard.
Henry, J. L. (1976) Effect of substance P on functionally identified units in cats’ spinal cord. Brain Res., 114, 439–52.
Hopkins, R., Bird, H. A., Hill, J., Surrall, K., Miller, A. and Wright, V. (1983) A double-blind controlled trial of tigason (etretinate) in psoriatic arthritis. Communication, Xth Eur. Congr. Rheumatol., Moscow, USSR.
Hopkins, R. and Bird, H. A. Personal communication.
Hughes, J. (1975) Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res., 88, 295–308.
Hughes, J., Smith, D. W. and Kosterlitz, H. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 285, 577–9.
Huskisson, E. C. (1974) Measurement of pain. Lancet, ii, 1127–31.
Huskisson, E. C., Jaffe, I. A. and Scott, J. (1980) 5-thiopyridoxine in RA: clinical and experimental studies. Arthr. Rheum., 23, 106–10.
Jaffe, M. E. (1983) Osmosin. A new continuously acting anti-arthritic. Curr. Med. Res. Opinion, Suppl. 2.
Jarrett, P. E. M., Morland, M. and Browse, N. L. (1978) Treatment of Raynaud’s phenomenon by firbrinolytic enhancement. Br. Med. J., ii, 523–5.
Jessel, T. M. and Iversen, L. L. (1977) Opiate analgesic inhibits substance P-release from rat trigeminal nucleus. Nature, 268, 549–51.
Jick, H. (1981) Effects of aspirin and acetaminophen in gastrointestinal haemorrhage. Arch. Intern. Med., 141, 316.
Jick, H. and Porter, J. (1978) Drug-induced gastrointestinal bleeding. Lancet, ii, 87.
Jones, J. V., Clough, J. D., Klinberg, J. R. and Davis, P. (1981) The role of therapeutic plasmapheresis in the rheumatic diseases. J. Lab. Clin. Med., 97/5, 589–98.
Khan, K. A., Howes, D. T., Piris, J. and Truelove, S. C. (1980) Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut, 21, 232–40.
Kondo, H., Rabin, B. S. and Rodnan, G. P. (1976) Cutaneous-antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). J. Clin. Invest., 58, 1388–94.
Kosterlitz, H. N., Lord, J. A. H. and Patterson, S. J. (1980) Effects of changes in structure of enkephalins and narcotic analgesic drugs on their interactions with receptors and receptors. Br. J. Pharmacol., 68, 333–42.
Kotzin, B. L. (1981) Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N. Engl. J. Med., 17, 969–76.
Kyle, M. V., Parr, G., Salisbury, R., Page Thomas, P. and Hazleman, B. L. (1982) PGE1 vasospastic disease and thermography. Ann. Rheum. Dis. 41, 310.
Lasagna, L. (1960) The clinical measurement of pain. Ann. N. Y. Acad. Sci., 86, 28–37.
Leading article (1978) Treatment of arthritis associated with psoriasis. Br. Med. J., 1, 262–3.
Leading article (1982) Total lymphoid irradiation in rheumatoid arthritis. Lancet, i, 25–7.
Levine, J. G., Gordon, N. C. and Fields, H. L. (1978) The mechanism of placebo analgesia. Lancet, ii, 654–6.
Levy, M. (1974) Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N. Engl. J. Med., 290, 1158.
Lund-Olesen, K. and Menander-Huber, K. B. (1983) Intra-articular orgotein therapy in osteoarthritis of the knee. A double-blind, placebo-controlled trial. Arzneimittelforschung, 33, 1199–203.
McCarty, D. J. and Carrera, G. F. (1982) Intractable rheumatoid arthritis: treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. J. Am. Med. Assoc., 248, 1718–23.
McKenna, F., Hickling, P., Martin, M. F. R., Sitton, N., Dixon, J. S. and Wright, V. (1983) Why is methylcysteine not an anti-rheumatoid drug? Heberden Soc., Leeds.
McKenna, F., Hopkins, R., Hinchcliffe, M. P., Bird, H. A. and Wright, V. (1985) Gold and penicillamine, alone and in combination, in active rheumatoid arthritis. Abstract D158, p. 221. XVIth International Congress of Rheumatology, Sydney.
Martin, M. F. R., Dowd, P. M., Ring, E. F. J., Cooke, E. D., Dieppe, P. A. and Kirby, J. D. T. (1981) Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. Ann. Rheum. Dis., 40, 350–4.
Martin, M. F. R., Dixon, J., Hickling, P., Bird, H., Golding, J. and Wright, V. (1982) A combination of D-penicillamine and hydroxychloroquine for the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 41, 208.
Martin, M. F. R., Surrall, K., McKenna, F., Dixon, J. S., Bird, H. A. and Wright, V. (1983) Captopril: a new long-term agent for treating rheumatoid arthritis. Ann. Rheum. Dis., 42, 231.
Martin, M. F. R. and Tooke, J. E. (1982) Effect of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis. Br. Med. J., 285, 1688–90.
Menys, V. C. and Davies, J. A. (1983) Selective inhibition of thromboxane synthetase with dazoxiben-basis of its inhibitory effect in platelet adhesion. Thrombosis Haemostasis, 49, 96–101.
Moldofsky, H., Lue, F. A. and Smythe, H. A. (1983) Alpha EEG sleep and morning symptoms in rheumatoid arthritis. J. Rheumatol., 10, 373–9.
Moldofsky, H. and Scarisbrick, P. (1976) Induction of neurasthenic musculo-skeletal pain syndrome by selected sleep deprivation. Psychosom. Med., 38, 35–44.
Neumann, V. C., Grindulis, K. A., Hubball, S., McConkey, B. and Wright, V. (1983) Comparison between penicillamine and sulphasalazine in rheumatoid arthritis. Leeds-Birmingham trial. Br. Med. J., 287, 1099–102.
Neumann, V. C., Taggart, A. J., Legauer, P., Astbury, C., Hill, J. and Bird, H. A. (1986) A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J. Rheum. (In press)
Nilsson, G. E., Tenland, T. and Oberg, P. A. (1980) Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans. Biomed. Engng, 27, 597–604.
O’Reilly, M. J. G., Talpos, G., Roberts, V. C., White, J. M. and Cotton, L. T. (1979) Controlled trial of plasma exchange in treatment of Raynaud’s syndrome. Br. Med. J., i, 113–15.
Pardy, B. J., Lewis, J. D. and Eastcott, H. H. G. (1980) Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease. Surgery, 88, 826–32.
Parrott, A. C. and Hindmarch, I. (1980) The Leeds sleep evaluation questionnaire in psychopharmacological investigations — a review. Psychopbarmacology, 71, 173–9.
Pasero, G. and Ciompi, M. L. (1979) Thiopronine therapy in rheumatoid arthritis. Artbr. Rheum., 32, 882–4.
Pullar, R., Hunter, J. A. and Capell, H. A. (1983) Sulphasalazine in rheumatoid arthritis: a double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br. Med. J., 287, 1102–4.
Pullar, T., Hunter, J. A., Capell, H. A. (1985) Which component of sulphasalazine is active in rheumatoid arthritis. Br. Med. J., 290, 1535–8.
Purlman, S. G., Gerber, L. H. and Roberts, M. (1979) Photochemotherapy and psoriatic arthritis: a prospective study. Ann. Intern. Med., 91, 717–22.
Randall, W. and Selitto, J. F. (1957) A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pbarmacodynam. Ther., 111, 409–19.
Ranlov, P. J., Nielsen, S. P. and Barenholdt, O. (1983) Faecal blood loss during culmination of acetylsalicylic acid, ketoprofen and a new ketoprofen sustained-release compound. Scand. J. Rheumatol., (In press).
Rhind, V. M., Bird, H. A. and Wright, V. (1980) A comparison of clinical assessments of disease activity in rheumatoid arthritis. Ann. Rheum. Dis., 39, 135–7.
Robinson, D. (1981) Principles of pharmcodynamics. in Textbook of Rheumatology (eds W. N. Kelly, E. Harris, S. Ruddy and C. Sledge), Saunders, Philadelphia, pp. 721–7.
Scott, D. G. I., Bacon, P. A., Bothamley, J., Allen, C., Elson, C. J. and Wallington, T. (1986) Plasma exchange in rheumatoid arthritis. (in preparation)
Scott, D. L., Roden, S., Marshall, T. and Kendall, M. J. (1982) Variations in responses to non-steroidal anti-inflammatory drugs. Br. J. Pharmacol., 14, 691–4.
Sinclair, R. J. G. and Duthie, J. J. R. (1948) Salazopyrin in the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 8, 226–31.
Smith, C. D. and McKendry, R. J. R. (1982) Controlled trial of nifedipine in the treatment of Raynaud’s phenomenon. Lancet, ii, 1299–301.
Smith, S. E. and Rawlins, M. D. (1973) Variability in Human Drug Response, Butter-worths, London.
Stranden, E., Roald, O. K. and Krohg, R. (1982) Treatment of Raynaud’s phenomenon with the 5-HT2-receptor antagonist ketanserin. Br. Med. J., 285, 1069–71.
Steven, M. M., Hunter, J. A., Murdock, R. M. and Capell, H. A. (1982) Does the order of second-line treatment in rheumatoid arthritis matter? Br. Med. J., 284, 79–80.
Stobo, J. D., Kennedy, M. S. and Goldyne, M. E. (1979) Prostaglandin E modulation of the mitogenic response of human T cells. J. Clin. Invest., 64, 1188–95.
Stone, P. H., Antman, E. M., Müller, J. E. and Braunwald, E. (1980) Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Haemodynamic effects and clinical applications. Ann. Intern. Med., 93, 886–904.
Svartz, N. (1942) Salazopyrin, a new sulfanilamide preparation. Acta Med. Scand. 110, 577–98.
Svartz, N. (1948) The treatment of rheumatic polyarthritis with acid azo compounds, in Rheumatism, 4, pp. 56–60.
Swinson, D. R., Zlosnick, J. and Jackson, L. (1981) Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 40, 235–9.
Theuwes, F. (1981) Drug delivery systems. Pharmacol. Ther., 13, 149–191.
Theuwes, F. and Yum, S. I. (1976) Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formatulations. Ann. Biomed. Engng, 4, 343–53.
Tindall, H., Tooke, J. E., Menys, V. C., Martin, M. F. R. and Davies, J. A. (1985) Effect of dazoxiben, a thromboxane synthetase inhibitor, on skin-blood flow following cold challenge in patients with Raynaud’s phenomenon. Eur. J. Clin. Invest., 15(1), 20–30.
Tooke, J. E., Ostergren, J. and Fagrell, B. (1986) Synchronous assessment of human skin microcirculation by laser doppler flowmetry and dynamic capillaroscopy. (in preparation)
Veys, E. M., Huskisson, E. C., Rosenthal, M., Vischer, T. L., Mielants, H., Thrower, P. A., Scott, J., Ott, H., Scheijgrond, H. and Symoens, J. (1982) Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Ann. Rheum. Dis., 41, 441–3.
Wright, V. and Hopkins, R. (1983) Administration of anti-rheumatic drugs. Ann. Rheum. Dis., 35, 229–31.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 J. M. H. Moll, H. A. Bird and A. Rushton
About this chapter
Cite this chapter
Wright, V. (1986). New drugs and experimental progress. In: Moll, J.M.H., Bird, H.A., Rushton, A. (eds) Therapeutics in Rheumatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2883-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2883-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-24540-4
Online ISBN: 978-1-4899-2883-2
eBook Packages: Springer Book Archive